Invasive Glioblastoma Cells Acquire Stemness and Increased Akt Activation

Invasive Glioblastoma Cells Acquire Stemness and Increased Akt Activation

Glioblastoma multiforme (GBM) is the most frequent and most aggressive brain tumor in adults. The dismal prognosis is due to postsurgery recurrences arising from escaped invasive tumor cells. The signaling pathways activated in invasive cells are under investigation, and models are currently designe...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Jennifer R. Molina, Yuho Hayashi, Clifton Stephens, Maria-Magdalena Georgescu
Format:	Artykuł
Język:	English
Wydane:	Elsevier 2010-06-01
Seria:	Neoplasia: An International Journal for Oncology Research
Dostęp online:	http://www.sciencedirect.com/science/article/pii/S147655861080003X

Podobne zapisy

FDFT1 maintains glioblastoma stem cells through activation of the Akt pathway
od: Hui Mo, i wsp.
Wydane: (2024-12-01)

PP242 Counteracts Glioblastoma Cell Proliferation, Migration, Invasiveness and Stemness Properties by Inhibiting mTORC2/AKT
od: Carmen Mecca, i wsp.
Wydane: (2018-04-01)

Glycation Leads to Increased Invasion of Glioblastoma Cells
od: Paola Schildhauer, i wsp.
Wydane: (2023-04-01)

NHERF1/EBP50 Is a New Marker in Colorectal Cancer
od: Yuho Hayashi, i wsp.
Wydane: (2010-12-01)

Prion protein regulates invasiveness in glioblastoma stem cells
od: Mariana B. Prado, i wsp.
Wydane: (2024-12-01)

Astrocytes enhance the invasion potential of glioblastoma stem-like cells.
od: Barbara H Rath, i wsp.
Wydane: (2013-01-01)

Radiation-induced Akt activation modulates radioresistance in human glioblastoma cells
od: Waldman Todd, i wsp.
Wydane: (2009-10-01)

Serglycin activates pro-tumorigenic signaling and controls glioblastoma cell stemness, differentiation and invasive potential
od: Dimitra Manou, i wsp.
Wydane: (2020-05-01)

TRIM28 Selective Nanobody Reduces Glioblastoma Stem Cell Invasion
od: Andrej Porčnik, i wsp.
Wydane: (2021-08-01)

Small cell glioblastoma: A glioblastoma subtype with an unexpected response
od: Ionela Bizu, i wsp.
Wydane: (2019-06-01)

The Glycoprotein M6a Is Associated with Invasiveness and Radioresistance of Glioblastoma Stem Cells
od: Marie Geraldine Lacore, i wsp.
Wydane: (2022-07-01)

Establishment and Characterization of a Tumor Stem Cell-Based Glioblastoma Invasion Model.
od: Stine Skov Jensen, i wsp.
Wydane: (2016-01-01)

Induction of Akt Activity by Chemotherapy Confers Acquired Resistance
od: Wei-Chien Huang, i wsp.
Wydane: (2009-03-01)

Towards Clinical AKT Inhibition in Glioblastoma
od: Hanah Gull, i wsp.
Wydane: (2023-01-01)

Absence of AKT1 mutations in glioblastoma.
od: Fonnet E Bleeker, i wsp.
Wydane: (2009-05-01)

Activated T cell therapy targeting glioblastoma cancer stem cells
od: Ken Miyaguchi, i wsp.
Wydane: (2023-01-01)

Zika Virus with Increased CpG Dinucleotide Frequencies Shows Oncolytic Activity in Glioblastoma Stem Cells
od: Ivan Trus, i wsp.
Wydane: (2020-05-01)

Neuropilin-1 modulates the 3D invasive properties of glioblastoma stem-like cells
od: Mathilde Kerhervé, i wsp.
Wydane: (2022-09-01)

EphrinB2 drives perivascular invasion and proliferation of glioblastoma stem-like cells
od: Benjamin Krusche, i wsp.
Wydane: (2016-06-01)

Mechanism of acquired temozolomide resistance in glioblastoma
od: McFaline-Figueroa, José L
Wydane: (2014)

Glioblastoma Multiforme Stem Cells
od: Irena Dimov, i wsp.
Wydane: (2011-01-01)

MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways
od: Xu Zhang, i wsp.
Wydane: (2021-01-01)

NHERF-1: Modulator of Glioblastoma Cell Migration and Invasion
od: Kerri L. Kislin, i wsp.
Wydane: (2009-04-01)

Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma
od: Rasime Kalkan
Wydane: (2015-11-01)

Molecular analyses of glioblastoma stem-like cells and glioblastoma tissue.
od: Marco Wallenborn, i wsp.
Wydane: (2020-01-01)

Glioblastoma Stem Cells as a New Therapeutic Target for Glioblastoma
od: Rasime Kalkan
Wydane: (2015-01-01)

Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer
od: Kirstine Jacobsen, i wsp.
Wydane: (2017-09-01)

Monocarboxylate transporter dependent mechanism is involved in proliferation, migration, and invasion of human glioblastoma cell lines via activation of PI3K/Akt signaling pathway.
od: Chen Gao, i wsp.
Wydane: (2024-01-01)

Adipose Tissue-Derived Stem Cell Extracellular Vesicles Suppress Glioblastoma Proliferation, Invasiveness and Angiogenesis
od: Dovydas Gečys, i wsp.
Wydane: (2023-04-01)

Napabucasin, a novel STAT3 inhibitor suppresses proliferation, invasion and stemness of glioblastoma cells
od: Dongfeng Han, i wsp.
Wydane: (2019-07-01)

Corrigendum: MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways
od: Xu Zhang, i wsp.
Wydane: (2022-04-01)

Insulin receptor substrate 1 overexpression promotes survival of glioblastoma cells through AKT1 activation
od: Gokhan Gorgisen, i wsp.
Wydane: (2020-03-01)

Engraftment of Human Glioblastoma Cells in Immunocompetent Rats through Acquired Immunosuppression.
od: Peter C Huszthy, i wsp.
Wydane: (2015-01-01)

Investigating acquired temozolomide resistance in adult glioblastoma
od: Wong, ZY
Wydane: (2020)

Tumor Stem Cells in Glioblastoma Multiforme
od: Mahbobeh Farokhpour
Wydane: (2012-06-01)

Cancer Stem Cells in Glioblastoma Multiforme
od: Amy Ruth Bradshaw, i wsp.
Wydane: (2016-08-01)

Single-cell chromatin accessibility profiling of glioblastoma identifies an invasive cancer stem cell population associated with lower survival
od: Paul Guilhamon, i wsp.
Wydane: (2021-01-01)

Glioblastoma stem cell (GSC)-derived PD-L1-containing exosomes activates AMPK/ULK1 pathway mediated autophagy to increase temozolomide-resistance in glioblastoma
od: Yong Zheng, i wsp.
Wydane: (2021-03-01)

The small GTPase RhoG mediates glioblastoma cell invasion
od: Kwiatkowska Aneta, i wsp.
Wydane: (2012-09-01)

Downregulation of Williams syndrome transcription factor (WSTF) suppresses glioblastoma cell growth and invasion by inhibiting PI3K/AKT signal pathway
od: Liyuan Yang, i wsp.
Wydane: (2021-11-01)